Narra Sarojini Devi

7.0k citations

22 papers · 5.5k · 1 hit paper · h-index 17

Impact in

Genetics top 0.5%
- Glioma Diagnosis and Treatment
Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research

Papers in

Cancer Research 13
- Cancer, Hypoxia, and Metabolism 12
Molecular Biology 13
- ATP Synthase and ATPases Research 4
- Epigenetics and DNA Methylation 3
- Metabolism, Diabetes, and Cancer 2
- Histone Deacetylase Inhibitors Research 2

Co-authors: Erwin G. Van Meir (19 shared papers)Daniel J. Brat (4 shared papers)Mourad Tighiouart (2 shared papers)Balveen Kaur (3 shared papers)Keith D. Wilkinson (1 shared paper)Kenneth L. Friedrich (1 shared paper)Tatiana Alexandrovna Chernova (1 shared paper)Karen Ventii (1 shared paper)
Journals: Clinical Cancer Research (5 papers)Cancer Research (3 papers)Oncogene (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Medicinal Chemistry (2 papers)
Partner nations: United States China Poland

In The Last Decade

Narra Sarojini Devi

22 papers receiving 5.4k citations

Narra Sarojini Devi's Hit Papers

align trajectories log scale

The Somatic Genomic Landscape of Glioblastoma 2013 · 4.0k citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2013 Cell

Peers

Countries citing papers authored by Narra Sarojini Devi

Since Specialization

Citations

This map shows the geographic impact of Narra Sarojini Devi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narra Sarojini Devi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narra Sarojini Devi more than expected).

Fields of papers citing papers by Narra Sarojini Devi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narra Sarojini Devi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narra Sarojini Devi. The network helps show where Narra Sarojini Devi may publish in the future.

Co-authors

The 25 scholars most cited alongside Narra Sarojini Devi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Narra Sarojini Devi Line = papers co-authored together Narra Sarojini Devi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Somatic Genomic Landscape of Glioblastoma Cell ·Cameron Brennan, Roel G.W. Verhaak, Aaron McKenna, Benito Campos, Houtan Noushmehr, Sofie Salama, Siyuan Zheng, Debyani Chakravarty Hit paper breakdown →	2013	3977
2	BRCA1-Associated Protein-1 Is a Tumor Suppressor that Requires Deubiquitinating Activity and Nuclear Localization Cancer Research ·Karen Ventii, Narra Sarojini Devi, Kenneth L. Friedrich, Tatiana Alexandrovna Chernova, Mourad Tighiouart, Erwin G. Van Meir, Keith D. Wilkinson	2008	290
3	Tyr Phosphorylation of PDP1 Toggles Recruitment between ACAT1 and SIRT3 to Regulate the Pyruvate Dehydrogenase Complex Molecular Cell ·Jun Fan, Changliang Shan, Hee‐Bum Kang, Shannon Elf, Jianxin Xie, Meghan Tucker, Ting‐Lei Gu, Mike Aguiar	2014	261
4	Vasculostatin, a proteolytic fragment of Brain Angiogenesis Inhibitor 1, is an antiangiogenic and antitumorigenic factor Oncogene ·Balveen Kaur, Daniel J. Brat, Narra Sarojini Devi, Erwin G. Van Meir	2005	153
5	Vasculostatin Inhibits Intracranial Glioma Growth and Negatively Regulates In vivo Angiogenesis through a CD36-Dependent Mechanism Cancer Research ·Balveen Kaur, Sarah M. Cork, Eric M. Sandberg, Narra Sarojini Devi, Zhaobin Zhang, Philip A. Klenotic, Maria Febbraio, Hyunsuk Shim	2009	110
6	Targeted Cancer Gene Therapy Using a Hypoxia Inducible Factor–Dependent Oncolytic Adenovirus Armed with Interleukin-4 Cancer Research ·Dawn E. Post, Eric M. Sandberg, Michele M. Kyle, Narra Sarojini Devi, Daniel J. Brat, Zhiheng Xu, Mourad Tighiouart, Erwin G. Van Meir	2007	95
7	Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP Clinical Cancer Research ·Shaoman Yin, Štefan Kaluz, Narra Sarojini Devi, Adnan Abdul Jabbar, Rita G. de Noronha, Ji-Young Mun, Zhaobin Zhang, Purushotham Reddy Boreddy	2012	73
8	BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation Cancer Cell ·Dan Zhu, Satoru Osuka, Zhaobin Zhang, Zachery Roger Reichert, Liquan Yang, Yonehiro Kanemura, Ying Jiang, Shuo You	2018	65
9	Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase Clinical Cancer Research ·Juliya Kalinina, Jun Young Ahn, Narra Sarojini Devi, Liya Wang, Yuancheng Li, Jeffrey J. Olson, Michael Glantz, Thomas Wayne Smith	2016	60
10	Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma Clinical Cancer Research ·Lei Dong, Shuo You, Qing Zhang, Satoru Osuka, Narra Sarojini Devi, Štefan Kaluz, Jalisa H. Ferguson, Hua Yang	2018	58
11	Cancer Therapy with a Replicating Oncolytic Adenovirus Targeting the Hypoxic Microenvironment of Tumors Clinical Cancer Research ·Dawn E. Post, Narra Sarojini Devi, Zhenchao Li, Daniel J. Brat, Balveen Kaur, Ainsley C. Nicholson, Jeffrey J. Olson, Zhaobin Zhang	2004	52
12	Design and in Vitro Activities of N-Alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, Novel, Small-Molecule Hypoxia Inducible Factor-1 Pathway Inhibitors and Anticancer Agents Journal of Medicinal Chemistry ·Ji-Young Mun, Adnan Abdul Jabbar, Narra Sarojini Devi, Shaoman Yin, Yingzhe Wang, Chalet Tan, Deborah G. Culver, James P. Snyder	2012	51
13	Design and Synthesis of Novel Small-Molecule Inhibitors of the Hypoxia Inducible Factor Pathway Journal of Medicinal Chemistry ·Suazette Reid Mooring, Hui Jin, Narra Sarojini Devi, Adnan Abdul Jabbar, Štefan Kaluz, Yuan Liu, Erwin G. Van Meir, Binghe Wang	2011	44
14	EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway Oncogene ·Hanwen Zhang, Dan Zhu, Zhaobin Zhang, Štefan Kaluz, Bing Yu, Narra Sarojini Devi, Jeffrey J. Olson, Erwin G. Van Meir	2019	34
15	Sulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors Bioorganic & Medicinal Chemistry Letters ·Chalet Tan, Rita G. de Noronha, Narra Sarojini Devi, Adnan Abdul Jabbar, Štefan Kaluz, Yuan Liu, Suazette Reid Mooring, K. C. Nicolaou	2011	31
16	Structure–activity relationship of 2,2-dimethyl-2H-chromene based arylsulfonamide analogs of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, a novel small molecule hypoxia inducible factor-1 (HIF-1) pathway inhibitor and anti-cancer agent Bioorganic & Medicinal Chemistry ·Ji-Young Mun, Adnan Abdul Jabbar, Narra Sarojini Devi, Yuan Liu, Erwin G. Van Meir, Mark M. Goodman	2012	31
17	Targeting HIF-activated collagen prolyl 4-hydroxylase expression disrupts collagen deposition and blocks primary and metastatic uveal melanoma growth Oncogene ·Štefan Kaluz, Qing Zhang, Yuki Kuranaga, Hua Yang, Satoru Osuka, Debanjan Bhattacharya, Narra Sarojini Devi, Ji-Young Mun	2021	30
18	Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription Cofactor ACS Medicinal Chemistry Letters ·Qi Shi, Shaoman Yin, Štefan Kaluz, Nanting Ni, Narra Sarojini Devi, Ji-Young Mun, Danzhu Wang, Krishna Damera	2012	15
19	Examining the structure-activity relationship of benzopyran-based inhibitors of the hypoxia inducible factor-1 pathway Bioorganic & Medicinal Chemistry Letters ·Jalisa H. Ferguson, Zeus A. De los Santos, Narra Sarojini Devi, Erwin G. Van Meir, Sarah Kathryn Zingales, Binghe Wang	2017	8
20	A Chimeric Signal Peptide–Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell–Specific Apoptosis Clinical Cancer Research ·Sok-Hyong Lee, Fatima Khwaja Rehman, Kari C. Tyler, Bing Yu, Zhaobin Zhang, Satoru Osuka, Abdessamad Zerrouqi, Milota Kaluzová	2020	8

About Narra Sarojini Devi

Narra Sarojini Devi is a scholar working on Cancer Research, Molecular Biology, Genetics, Biochemistry and Ophthalmology, having authored 22 papers that have together received 5.5k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (12 papers), ATP Synthase and ATPases Research (4 papers), Epigenetics and DNA Methylation (3 papers), Cancer-related Molecular Pathways (3 papers), Cancer Research and Treatments (2 papers), Glioma Diagnosis and Treatment (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Genetics (2.1k citations), Cancer Research (1.7k citations), Molecular Biology (2.8k citations), Oncology (865 citations) and Geriatrics and Gerontology (99 citations). Narra Sarojini Devi has collaborated with scholars based in United States, China and Poland. Frequent co-authors include Erwin G. Van Meir, Daniel J. Brat, Mourad Tighiouart, Balveen Kaur, Keith D. Wilkinson, Kenneth L. Friedrich, Tatiana Alexandrovna Chernova, Karen Ventii, Zhaobin Zhang and Štefan Kaluz. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Oncogene, Bioorganic & Medicinal Chemistry Letters and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Narra Sarojini Devi

Impact in

Papers in i

In The Last Decade

Narra Sarojini Devi

Narra Sarojini Devi's Hit Papers

Peers

Countries citing papers authored by Narra Sarojini Devi

Fields of papers citing papers by Narra Sarojini Devi

All Works

About Narra Sarojini Devi

Explore authors with similar magnitude of impact

Papers in